-
Biologic treatment expansion leads to population-level reductions in asthma exacerbations
Findings show that beginning in 2015, annual exacerbation events decreased by 474.1 events per 1,000 patients per year and have continued to decline by 206.5 events per 1,000 patients per year.
Recent News
-
FDA approval of oveporexton for narcolepsy allows clinicians to treat more than symptoms
When the US Food and Drug Administration approved the drug in August, oveporexton became the first agent to target the loss of orexin signaling that causes narcolepsy type 1.
-
Study shows association between higher vitamin A levels and better lung function
The results linked higher vitamin A levels with better lung function in children and adults with asthma, while vitamin D showed a similar association primarily in adults.
-
Point-of-care respiratory virus testing in nursing homes could reduce transfers to EDs
A recent study showed that onsite POC-RM-PCR testing resulted in an 11% absolute reduction in the probability of emergency department transfer during an outbreak.
-
Low-nicotine cigarettes unlikely to trigger sustained compensatory smoking, meta-analysis finds
Hasmeena Kathuria, MD, said the findings provide further support that very low nicotine content cigarettes do not lead to substantially increased smoking or carbon monoxide exposure.
-
Air pollution and dysglycemia: Implications for pulmonary practice
Air pollution exposure is linked to incident diabetes and adverse glycemic biomarkers. Clinicians can help patients assess their exposure and provide practical counseling.
-
Matters of the right heart: Applying the 2025 ASE guidelines in PH practice
The latest guidelines from the American Society of Echocardiography emphasize three pillars of right-heart assessment: structure, function, and hemodynamics.
